 |
About Ed Francis
DistilNFO's Executive Editor & Senior Industry Strategist.
Ed is the National Life Sciences Practice lead for West Monroe Partners & has more than 20 years of management consulting experience guiding some of the industry’s most prominent organizations.
Subscribe to the Newsletter Here |
|
|
After small-scale manufacturing of a new product in the lab, it must be transferred for manufacturing on a larger scale. High volume manufacturing can either be done by the original company that produced the product, or it can be taken-over...
|
|
|
|
|
|
Your physical and even mental health is a growing focus for Fitbit as it tries to fill the revenue gap left by a stalled business in fitness trackers. Fitbit has a problem on its hands. This is not news. After riding high on a 2015 IPO, Fit...
|
|
|
|
|
|
Jared Lewis, freelance healthcare contributor, explains how in the value-based medicine race, Xenco Medical has emerged with a novel way to win. With the unsustainability of health system costs reaching boiling point and the pressure to ...
|
|
|
|
|
|
Pain Therapeutics can’t seem to take a break. On Tuesday, an FDA panel voted against the approval of Remoxy ER, its extended-release, capsule gel form of the opioid oxycodone. The Austin, Texas-based company licensed Remoxy ER from ...
|
|
|
|
|
|
Precision BioSciences has raised $110 million. The series B round sets the genome editing specialist up to take its lead, off-the-shelf CAR-T therapy into clinical trials. North Carolina-based Precision is built around Arcus, a genome ...
|
|
|
|
|
|
Celgene is launching a $60 million collaboration with Skyhawk Therapeutics to develop and commercialize small molecules targeting RNA mis-splicing in neurological diseases. Under the deal, Celgene received the exclusive option to license up...
|
|
|
|
|
|
The Dementia Discovery Fund (DDF) completed its fundraising Monday, capping its haul at £250 million ($350 million). The VC fund, backed by various entities, including government departments and Big Pharma, was nudged across the finish ...
|
|
|
|
|
|
The executive pyramid at Johnson & Johnson is going through a significant revamp with head of pharmaceuticals Joaquin Duato taking on most of the responsibilities held by Group Worldwide Chairman Sandra Peterson as she prepares to ...
|
|
|
|
|
|
When Shionogi got Japanese approval for its novel flu drug Xofluza (baloxavir marboxil) in February, it didn’t expect a U.S. decision in 2018. Now, an FDA priority review has made it possible for its partner Roche to get a go-ahead before...
|
|
|
|
|
|
In April 2017 the new EU Medical Devices Regulation and the EU in vitro Diagnostics Regulation (together, the ‘Regulations’) were adopted by the European Parliament, entering into force on 25 May 2017. The Regulations state that ...
|
|
|
|
|
Advertise with us
We Reach Quarter Million Decision Makers in:
Healthcare | IT | Retail | Industrial
Advertise with us and reach the right audience.
|
